Advertisement

Index by author

March 01, 1989; Volume 248,Issue 3

A

  1. Aanonsen, L M

    1. Muscimol, gamma-aminobutyric acidA receptors and excitatory amino acids in the mouse spinal cord.
      L M Aanonsen and G L Wilcox
      Journal of Pharmacology and Experimental Therapeutics March 1989, 248 (3) 1034-1038;

  2. Aas, A T

    1. Effect of anti-inflammatory analgesic drugs on the regulation of cytosolic pH by anion antiport.
      T I Tønnessen, A T Aas, K Sandvig and S Olsnes
      Journal of Pharmacology and Experimental Therapeutics March 1989, 248 (3) 1197-1206;

  3. Abels, B C

    1. Inhibition of renal vasoconstriction induced by intrarenal hypertonic saline by the nonxanthine adenosine antagonist CGS 15943A.
      J T Callis, C J Kuan, K R Branch, B C Abels, R Sabra, E K Jackson and R A Branch
      Journal of Pharmacology and Experimental Therapeutics March 1989, 248 (3) 1123-1129;

  4. Adrien, J

    1. Biochemical and electrophysiological evidence for an agonist action of CM 57493 at pre- and postsynaptic 5-hydroxytryptamine1A receptors in brain.
      J Adrien, L Lanfumey, H Gozlan, C M Fattaccini and M Hamon
      Journal of Pharmacology and Experimental Therapeutics March 1989, 248 (3) 1222-1230;

  5. Akahane, K

    1. Beta-2 adrenoceptor-mediated effects on sinus rate and atrial and ventricular contractility on isolated, blood-perfused dog heart preparations.
      K Akahane, Y Furukawa, Y Ogiwara, M Haniuda and S Chiba
      Journal of Pharmacology and Experimental Therapeutics March 1989, 248 (3) 1276-1282;

  6. Andreasen, F

    1. Dose dependency of furosemide-induced sodium excretion.
      F Andreasen, I N Lauridsen, F A Hansen, S Christensen and E Steiness
      Journal of Pharmacology and Experimental Therapeutics March 1989, 248 (3) 1182-1188;

  7. Arnsdorf, M F

    1. Effects of ethmozin on excitability in sheep Purkinje fibers: the balance among active and passive cellular properties which comprise the electrophysiologic matrix.
      M F Arnsdorf and G J Sawicki
      Journal of Pharmacology and Experimental Therapeutics March 1989, 248 (3) 1158-1166;

B

  1. Babany, G

    1. In vivo evaluation of the effects of altered cyclosporine metabolism on its immunosuppressive potency.
      G Babany, R E Morris, I Babany, S Shepherd and R E Kates
      Journal of Pharmacology and Experimental Therapeutics March 1989, 248 (3) 893-899;

  2. Babany, I

    1. In vivo evaluation of the effects of altered cyclosporine metabolism on its immunosuppressive potency.
      G Babany, R E Morris, I Babany, S Shepherd and R E Kates
      Journal of Pharmacology and Experimental Therapeutics March 1989, 248 (3) 893-899;

  3. Badr, M Z

    1. Hepatotoxicity of menadione predominates in oxygen-rich zones of the liver lobule.
      M Z Badr, P E Ganey, H Yoshihara, F C Kauffman and R G Thurman
      Journal of Pharmacology and Experimental Therapeutics March 1989, 248 (3) 1317-1322;

  4. Balster, R L

    1. Effects of phencyclidine-like drugs on punished behavior in rats.
      J H Porter, J L Wiley and R L Balster
      Journal of Pharmacology and Experimental Therapeutics March 1989, 248 (3) 997-1002;

  5. Bergman, J

    1. Effects of kappa opioids on schedule-controlled behavior of squirrel monkeys.
      J Bergman and P H Warren
      Journal of Pharmacology and Experimental Therapeutics March 1989, 248 (3) 1102-1108;

  6. Bigelow, G E

    1. Antagonist effects of nalbuphine in opioid-dependent human volunteers.
      K L Preston, G E Bigelow and I A Liebson
      Journal of Pharmacology and Experimental Therapeutics March 1989, 248 (3) 929-937;

  7. Billman, G E

    1. Effect of calcium channel antagonists on susceptibility to sudden cardiac death: protection from ventricular fibrillation.
      G E Billman
      Journal of Pharmacology and Experimental Therapeutics March 1989, 248 (3) 1334-1342;

  8. Boarder, M R

    1. Characterization of bradykinin-stimulated release of noradrenaline from cultured bovine adrenal chromaffin cells.
      P J Owen, R Plevin and M R Boarder
      Journal of Pharmacology and Experimental Therapeutics March 1989, 248 (3) 1231-1236;

  9. Boeynaems, J M

    1. Interaction between nonsteroidal anti-inflammatory drugs and loop diuretics: modulation by sodium balance.
      A Herchuelz, F Derenne, F Deger, M Juvent, E Van Ganse, M Staroukine, A Verniory, J M Boeynaems and J Douchamps
      Journal of Pharmacology and Experimental Therapeutics March 1989, 248 (3) 1175-1181;

  10. Branch, K R

    1. Inhibition of renal vasoconstriction induced by intrarenal hypertonic saline by the nonxanthine adenosine antagonist CGS 15943A.
      J T Callis, C J Kuan, K R Branch, B C Abels, R Sabra, E K Jackson and R A Branch
      Journal of Pharmacology and Experimental Therapeutics March 1989, 248 (3) 1123-1129;

  11. Branch, R A

    1. Inhibition of renal vasoconstriction induced by intrarenal hypertonic saline by the nonxanthine adenosine antagonist CGS 15943A.
      J T Callis, C J Kuan, K R Branch, B C Abels, R Sabra, E K Jackson and R A Branch
      Journal of Pharmacology and Experimental Therapeutics March 1989, 248 (3) 1123-1129;

  12. Brass, E P

    1. Coupling of hepatic prostaglandin receptors to adenylate cyclase through a pertussis toxin sensitive guanine nucleotide regulatory protein.
      M J Garrity, M M Reed and E P Brass
      Journal of Pharmacology and Experimental Therapeutics March 1989, 248 (3) 979-983;

  13. Bunney, B S

    1. Pharmacological characterization of the receptor mediating electrophysiological responses to dopamine in the rat medial prefrontal cortex: a microiontophoretic study.
      S R Sesack and B S Bunney
      Journal of Pharmacology and Experimental Therapeutics March 1989, 248 (3) 1323-1333;

  14. Burke, J T

    1. Pharmacokinetics, brain distribution and pharmaco-electrocorticographic profile of zolpidem, a new hypnotic, in the rat.
      D Garrigou-Gadenne, J T Burke, A Durand, H Depoortere, J P Thénot and P L Morselli
      Journal of Pharmacology and Experimental Therapeutics March 1989, 248 (3) 1283-1288;

  15. Burnashev, N A

    1. Single channel sodium current in rat cardiomyocytes: use-dependent block by ethacizin.
      A I Undrovinas, N A Burnashev, V V Nesterenko, J C Makielski, I A Fleidervish, H A Fozzard and L V Rosenshtraukh
      Journal of Pharmacology and Experimental Therapeutics March 1989, 248 (3) 1138-1145;

C

  1. Callis, J T

    1. Inhibition of renal vasoconstriction induced by intrarenal hypertonic saline by the nonxanthine adenosine antagonist CGS 15943A.
      J T Callis, C J Kuan, K R Branch, B C Abels, R Sabra, E K Jackson and R A Branch
      Journal of Pharmacology and Experimental Therapeutics March 1989, 248 (3) 1123-1129;

  2. Carp, J S

    1. Prevention of phencyclidine-induced depression of the segmental reflex by L-3,4-dihydroxyphenylalanine in the rat spinal cord in vitro.
      J S Carp, Y Ohno and J E Warnick
      Journal of Pharmacology and Experimental Therapeutics March 1989, 248 (3) 1048-1053;

  3. Caughey, G H

    1. Mast cell tryptase and chymase reverse airway smooth muscle relaxation induced by vasoactive intestinal peptide in the ferret.
      G M Franconi, P D Graf, S C Lazarus, J A Nadel and G H Caughey
      Journal of Pharmacology and Experimental Therapeutics March 1989, 248 (3) 947-951;

  4. Cavero, I

    1. Vasorelaxant effects of cromakalim in rats are mediated by glibenclamide-sensitive potassium channels.
      I Cavero, S Mondot and M Mestre
      Journal of Pharmacology and Experimental Therapeutics March 1989, 248 (3) 1261-1268;

  5. Chau, T T

    1. Pemedolac: a novel and long-acting non-narcotic analgesic.
      T T Chau and B M Weichman
      Journal of Pharmacology and Experimental Therapeutics March 1989, 248 (3) 907-915;

  6. Chiba, S

    1. Beta-2 adrenoceptor-mediated effects on sinus rate and atrial and ventricular contractility on isolated, blood-perfused dog heart preparations.
      K Akahane, Y Furukawa, Y Ogiwara, M Haniuda and S Chiba
      Journal of Pharmacology and Experimental Therapeutics March 1989, 248 (3) 1276-1282;

  7. Christensen, S

    1. Dose dependency of furosemide-induced sodium excretion.
      F Andreasen, I N Lauridsen, F A Hansen, S Christensen and E Steiness
      Journal of Pharmacology and Experimental Therapeutics March 1989, 248 (3) 1182-1188;

  8. Clayton, L M

    1. Role of bile acid conjugation in hepatic transport of dihydroxy bile acids.
      L M Clayton, D Gurantz, A F Hofmann, L R Hagey and C D Schteingart
      Journal of Pharmacology and Experimental Therapeutics March 1989, 248 (3) 1130-1137;

  9. Cohen, M L

    1. Contractile responses in bladder body, bladder neck and prostate from rat, guinea pig and cat.
      M L Cohen and K Drey
      Journal of Pharmacology and Experimental Therapeutics March 1989, 248 (3) 1063-1068;

  10. Collins, T D

    1. Differential effects of acute ethanol on urinary excretion of folate derivatives in the rat.
      B H Eisenga, T D Collins and K E McMartin
      Journal of Pharmacology and Experimental Therapeutics March 1989, 248 (3) 916-922;

  11. Cragoe, E J

    1. Influence of atrial natriuretic factor on 5-(N-ethyl-N-isopropyl)amiloride-sensitive 22Na+ uptake in rabbit aorta.
      S Gupta, E J Cragoe and R C Deth
      Journal of Pharmacology and Experimental Therapeutics March 1989, 248 (3) 991-996;

  12. Creese, I

    1. Irreversible and quaternary muscarinic antagonists discriminate multiple muscarinic receptor binding sites in rat brain.
      A B Norman, J H Eubanks and I Creese
      Journal of Pharmacology and Experimental Therapeutics March 1989, 248 (3) 1116-1122;

D

  1. Deger, F

    1. Interaction between nonsteroidal anti-inflammatory drugs and loop diuretics: modulation by sodium balance.
      A Herchuelz, F Derenne, F Deger, M Juvent, E Van Ganse, M Staroukine, A Verniory, J M Boeynaems and J Douchamps
      Journal of Pharmacology and Experimental Therapeutics March 1989, 248 (3) 1175-1181;

  2. deGroat, W C

    1. Selective inhibitory effects of ethylketocyclazocine on reflex pathways to the external urethral sphincter of the cat.
      K B Thor, T Hisamitsu, J R Roppolo, P Tuttle, J Nagel and W C deGroat
      Journal of Pharmacology and Experimental Therapeutics March 1989, 248 (3) 1018-1025;

  3. de Jong, W

    1. Differential effects of dopaminergic drugs on open-field behavior of spontaneously hypertensive rats and normotensive Wistar-Kyoto rats.
      M van den Buuse and W de Jong
      Journal of Pharmacology and Experimental Therapeutics March 1989, 248 (3) 1189-1196;

  4. del Balzo, U

    1. C3a-induced contraction of guinea pig ileum consists of two components: fast histamine-mediated and slow prostanoid-mediated.
      U del Balzo, M J Polley and R Levi
      Journal of Pharmacology and Experimental Therapeutics March 1989, 248 (3) 1003-1009;

  5. Depoortere, H

    1. Pharmacokinetics, brain distribution and pharmaco-electrocorticographic profile of zolpidem, a new hypnotic, in the rat.
      D Garrigou-Gadenne, J T Burke, A Durand, H Depoortere, J P Thénot and P L Morselli
      Journal of Pharmacology and Experimental Therapeutics March 1989, 248 (3) 1283-1288;

  6. Derenne, F

    1. Interaction between nonsteroidal anti-inflammatory drugs and loop diuretics: modulation by sodium balance.
      A Herchuelz, F Derenne, F Deger, M Juvent, E Van Ganse, M Staroukine, A Verniory, J M Boeynaems and J Douchamps
      Journal of Pharmacology and Experimental Therapeutics March 1989, 248 (3) 1175-1181;

  7. Deth, R C

    1. Influence of atrial natriuretic factor on 5-(N-ethyl-N-isopropyl)amiloride-sensitive 22Na+ uptake in rabbit aorta.
      S Gupta, E J Cragoe and R C Deth
      Journal of Pharmacology and Experimental Therapeutics March 1989, 248 (3) 991-996;

  8. Dibona, G F

    1. Role of renal nerves in excretory responses to exogenous and endogenous opioid peptides.
      D R Kapusta, S Y Jones, U C Kopp and G F Dibona
      Journal of Pharmacology and Experimental Therapeutics March 1989, 248 (3) 1039-1047;

  9. Douchamps, J

    1. Interaction between nonsteroidal anti-inflammatory drugs and loop diuretics: modulation by sodium balance.
      A Herchuelz, F Derenne, F Deger, M Juvent, E Van Ganse, M Staroukine, A Verniory, J M Boeynaems and J Douchamps
      Journal of Pharmacology and Experimental Therapeutics March 1989, 248 (3) 1175-1181;

  10. Drey, K

    1. Contractile responses in bladder body, bladder neck and prostate from rat, guinea pig and cat.
      M L Cohen and K Drey
      Journal of Pharmacology and Experimental Therapeutics March 1989, 248 (3) 1063-1068;

  11. Durand, A

    1. Pharmacokinetics, brain distribution and pharmaco-electrocorticographic profile of zolpidem, a new hypnotic, in the rat.
      D Garrigou-Gadenne, J T Burke, A Durand, H Depoortere, J P Thénot and P L Morselli
      Journal of Pharmacology and Experimental Therapeutics March 1989, 248 (3) 1283-1288;

E

  1. Eisenga, B H

    1. Differential effects of acute ethanol on urinary excretion of folate derivatives in the rat.
      B H Eisenga, T D Collins and K E McMartin
      Journal of Pharmacology and Experimental Therapeutics March 1989, 248 (3) 916-922;

  2. Eubanks, J H

    1. Irreversible and quaternary muscarinic antagonists discriminate multiple muscarinic receptor binding sites in rat brain.
      A B Norman, J H Eubanks and I Creese
      Journal of Pharmacology and Experimental Therapeutics March 1989, 248 (3) 1116-1122;

F

  1. Fattaccini, C M

    1. Biochemical and electrophysiological evidence for an agonist action of CM 57493 at pre- and postsynaptic 5-hydroxytryptamine1A receptors in brain.
      J Adrien, L Lanfumey, H Gozlan, C M Fattaccini and M Hamon
      Journal of Pharmacology and Experimental Therapeutics March 1989, 248 (3) 1222-1230;

  2. Ferguson, R K

    1. Ranitidine-induced changes in the renal and hepatic clearances of procainamide are correlated.
      M L Rocci, T Kosoglou, R K Ferguson and P H Vlasses
      Journal of Pharmacology and Experimental Therapeutics March 1989, 248 (3) 923-928;

  3. Ferrendelli, C A

    1. Affinities of different cholinergic agonists for the high and low affinity states of hippocampal M1 muscarine receptors.
      L T Potter and C A Ferrendelli
      Journal of Pharmacology and Experimental Therapeutics March 1989, 248 (3) 974-978;

  4. Fleidervish, I A

    1. Single channel sodium current in rat cardiomyocytes: use-dependent block by ethacizin.
      A I Undrovinas, N A Burnashev, V V Nesterenko, J C Makielski, I A Fleidervish, H A Fozzard and L V Rosenshtraukh
      Journal of Pharmacology and Experimental Therapeutics March 1989, 248 (3) 1138-1145;

  5. Fozzard, H A

    1. Single channel sodium current in rat cardiomyocytes: use-dependent block by ethacizin.
      A I Undrovinas, N A Burnashev, V V Nesterenko, J C Makielski, I A Fleidervish, H A Fozzard and L V Rosenshtraukh
      Journal of Pharmacology and Experimental Therapeutics March 1989, 248 (3) 1138-1145;

  6. Franconi, G M

    1. Mast cell tryptase and chymase reverse airway smooth muscle relaxation induced by vasoactive intestinal peptide in the ferret.
      G M Franconi, P D Graf, S C Lazarus, J A Nadel and G H Caughey
      Journal of Pharmacology and Experimental Therapeutics March 1989, 248 (3) 947-951;

  7. Furukawa, Y

    1. Beta-2 adrenoceptor-mediated effects on sinus rate and atrial and ventricular contractility on isolated, blood-perfused dog heart preparations.
      K Akahane, Y Furukawa, Y Ogiwara, M Haniuda and S Chiba
      Journal of Pharmacology and Experimental Therapeutics March 1989, 248 (3) 1276-1282;

G

  1. Ganey, P E

    1. Hepatotoxicity of menadione predominates in oxygen-rich zones of the liver lobule.
      M Z Badr, P E Ganey, H Yoshihara, F C Kauffman and R G Thurman
      Journal of Pharmacology and Experimental Therapeutics March 1989, 248 (3) 1317-1322;

  2. Garrigou-Gadenne, D

    1. Pharmacokinetics, brain distribution and pharmaco-electrocorticographic profile of zolpidem, a new hypnotic, in the rat.
      D Garrigou-Gadenne, J T Burke, A Durand, H Depoortere, J P Thénot and P L Morselli
      Journal of Pharmacology and Experimental Therapeutics March 1989, 248 (3) 1283-1288;

  3. Garrity, M J

    1. Coupling of hepatic prostaglandin receptors to adenylate cyclase through a pertussis toxin sensitive guanine nucleotide regulatory protein.
      M J Garrity, M M Reed and E P Brass
      Journal of Pharmacology and Experimental Therapeutics March 1989, 248 (3) 979-983;

  4. Gaver, A

    1. Chronic benzodiazepine administration. III. Upregulation of gamma-aminobutyric acidA receptor binding and function associated with chronic benzodiazepine antagonist administration.
      L G Miller, D J Greenblatt, R B Roy, A Gaver, F Lopez and R I Shader
      Journal of Pharmacology and Experimental Therapeutics March 1989, 248 (3) 1096-1101;

  5. George, R

    1. Characterization of the effects of the acute and chronic administration of phencyclidine on body temperature in the rat: lack of evidence for the involvement of opiate receptors.
      R N Pechnick and R George
      Journal of Pharmacology and Experimental Therapeutics March 1989, 248 (3) 900-906;

  6. Gozlan, H

    1. Biochemical and electrophysiological evidence for an agonist action of CM 57493 at pre- and postsynaptic 5-hydroxytryptamine1A receptors in brain.
      J Adrien, L Lanfumey, H Gozlan, C M Fattaccini and M Hamon
      Journal of Pharmacology and Experimental Therapeutics March 1989, 248 (3) 1222-1230;

  7. Graf, P D

    1. Mast cell tryptase and chymase reverse airway smooth muscle relaxation induced by vasoactive intestinal peptide in the ferret.
      G M Franconi, P D Graf, S C Lazarus, J A Nadel and G H Caughey
      Journal of Pharmacology and Experimental Therapeutics March 1989, 248 (3) 947-951;

  8. Greenblatt, D J

    1. Relationship of plasma and brain concentrations of caffeine and metabolites to benzodiazepine receptor binding and locomotor activity.
      G B Kaplan, D J Greenblatt, B W Leduc, M L Thompson and R I Shader
      Journal of Pharmacology and Experimental Therapeutics March 1989, 248 (3) 1078-1083;
    2. Chronic benzodiazepine administration. III. Upregulation of gamma-aminobutyric acidA receptor binding and function associated with chronic benzodiazepine antagonist administration.
      L G Miller, D J Greenblatt, R B Roy, A Gaver, F Lopez and R I Shader
      Journal of Pharmacology and Experimental Therapeutics March 1989, 248 (3) 1096-1101;

  9. Gregus, Z

    1. Biliary excretion of acetaminophen-glutathione as an index of toxic activation of acetaminophen: effect of chemicals that alter acetaminophen hepatotoxicity.
      C Madhu, Z Gregus and C D Klaassen
      Journal of Pharmacology and Experimental Therapeutics March 1989, 248 (3) 1069-1077;

  10. Griffiths, R R

    1. Evaluation of the abuse potential of methocarbamol.
      K L Preston, J J Guarino, W T Kirk and R R Griffiths
      Journal of Pharmacology and Experimental Therapeutics March 1989, 248 (3) 1146-1157;

  11. Guarino, J J

    1. Evaluation of the abuse potential of methocarbamol.
      K L Preston, J J Guarino, W T Kirk and R R Griffiths
      Journal of Pharmacology and Experimental Therapeutics March 1989, 248 (3) 1146-1157;

  12. Gupta, S

    1. Influence of atrial natriuretic factor on 5-(N-ethyl-N-isopropyl)amiloride-sensitive 22Na+ uptake in rabbit aorta.
      S Gupta, E J Cragoe and R C Deth
      Journal of Pharmacology and Experimental Therapeutics March 1989, 248 (3) 991-996;

  13. Gurantz, D

    1. Role of bile acid conjugation in hepatic transport of dihydroxy bile acids.
      L M Clayton, D Gurantz, A F Hofmann, L R Hagey and C D Schteingart
      Journal of Pharmacology and Experimental Therapeutics March 1989, 248 (3) 1130-1137;

H

  1. Hagey, L R

    1. Role of bile acid conjugation in hepatic transport of dihydroxy bile acids.
      L M Clayton, D Gurantz, A F Hofmann, L R Hagey and C D Schteingart
      Journal of Pharmacology and Experimental Therapeutics March 1989, 248 (3) 1130-1137;

  2. Hamon, M

    1. Biochemical and electrophysiological evidence for an agonist action of CM 57493 at pre- and postsynaptic 5-hydroxytryptamine1A receptors in brain.
      J Adrien, L Lanfumey, H Gozlan, C M Fattaccini and M Hamon
      Journal of Pharmacology and Experimental Therapeutics March 1989, 248 (3) 1222-1230;

  3. Handley, D A

    1. Terbinafine inhibits the mitogenic response to platelet-derived growth factor in vitro and neointimal proliferation in vivo.
      G M Nemecek, I H St Denny, R G Van Valen, L A McCarthy, D A Handley and A Stütz
      Journal of Pharmacology and Experimental Therapeutics March 1989, 248 (3) 1167-1174;

  4. Haniuda, M

    1. Beta-2 adrenoceptor-mediated effects on sinus rate and atrial and ventricular contractility on isolated, blood-perfused dog heart preparations.
      K Akahane, Y Furukawa, Y Ogiwara, M Haniuda and S Chiba
      Journal of Pharmacology and Experimental Therapeutics March 1989, 248 (3) 1276-1282;

  5. Hansen, F A

    1. Dose dependency of furosemide-induced sodium excretion.
      F Andreasen, I N Lauridsen, F A Hansen, S Christensen and E Steiness
      Journal of Pharmacology and Experimental Therapeutics March 1989, 248 (3) 1182-1188;

  6. Heran, C L

    1. Effect of thromboxane receptor antagonists on venous thrombosis in rats.
      W A Schumacher and C L Heran
      Journal of Pharmacology and Experimental Therapeutics March 1989, 248 (3) 1109-1115;

  7. Herchuelz, A

    1. Interaction between nonsteroidal anti-inflammatory drugs and loop diuretics: modulation by sodium balance.
      A Herchuelz, F Derenne, F Deger, M Juvent, E Van Ganse, M Staroukine, A Verniory, J M Boeynaems and J Douchamps
      Journal of Pharmacology and Experimental Therapeutics March 1989, 248 (3) 1175-1181;

  8. Herz, A

    1. Peripheral opioid receptors mediating antinociception in inflammation. Evidence for involvement of mu, delta and kappa receptors.
      C Stein, M J Millan, T S Shippenberg, K Peter and A Herz
      Journal of Pharmacology and Experimental Therapeutics March 1989, 248 (3) 1269-1275;

  9. Hisamitsu, T

    1. Selective inhibitory effects of ethylketocyclazocine on reflex pathways to the external urethral sphincter of the cat.
      K B Thor, T Hisamitsu, J R Roppolo, P Tuttle, J Nagel and W C deGroat
      Journal of Pharmacology and Experimental Therapeutics March 1989, 248 (3) 1018-1025;

  10. Hisano, K

    1. Isosorbide dinitrate ameliorates myocardial ischemia after development of collateral function in a canine model.
      K Hisano, H Tomoike, T Inoue, M Mohri and M Nakamura
      Journal of Pharmacology and Experimental Therapeutics March 1989, 248 (3) 1289-1296;

  11. Hofmann, A F

    1. Role of bile acid conjugation in hepatic transport of dihydroxy bile acids.
      L M Clayton, D Gurantz, A F Hofmann, L R Hagey and C D Schteingart
      Journal of Pharmacology and Experimental Therapeutics March 1989, 248 (3) 1130-1137;

  12. Holtzman, S G

    1. Opioid- and phencyclidine-like discriminative effects of ditolylguanidine, a selective sigma ligand.
      S G Holtzman
      Journal of Pharmacology and Experimental Therapeutics March 1989, 248 (3) 1054-1062;

  13. Hong, J S

    1. Lithium increases rat striatal beta- and gamma-preprotachykinin messenger RNAs.
      S P Sivam, J E Krause, K Takeuchi, S Li, J F McGinty and J S Hong
      Journal of Pharmacology and Experimental Therapeutics March 1989, 248 (3) 1297-1301;

  14. Hori, R

    1. Blood oxygen tension-related change of theophylline clearance in experimental hypoxemia.
      I Kishimoto, Y Tanigawara, K Okumura and R Hori
      Journal of Pharmacology and Experimental Therapeutics March 1989, 248 (3) 1237-1242;

  15. Hsueh, W

    1. Pharmacological manipulation of inflammation in rabbit hydronephrosis: effects of a combined cyclooxygenase/lipoxygenase inhibitor ethoxyquin, a thromboxane synthase inhibitor RS-5186 and a PAF antagonist L-659,989.
      S M Spaethe, W Hsueh and P Needleman
      Journal of Pharmacology and Experimental Therapeutics March 1989, 248 (3) 1308-1316;

  16. Hwang, A S

    1. Baclofen, gamma-aminobutyric acidB receptors and substance P in the mouse spinal cord.
      A S Hwang and G L Wilcox
      Journal of Pharmacology and Experimental Therapeutics March 1989, 248 (3) 1026-1033;

I

  1. Inoue, T

    1. Isosorbide dinitrate ameliorates myocardial ischemia after development of collateral function in a canine model.
      K Hisano, H Tomoike, T Inoue, M Mohri and M Nakamura
      Journal of Pharmacology and Experimental Therapeutics March 1989, 248 (3) 1289-1296;

  2. Izumi, N

    1. Mechanism of increased hepatotoxicity of acetaminophen by the simultaneous administration of caffeine in the rat.
      C Sato and N Izumi
      Journal of Pharmacology and Experimental Therapeutics March 1989, 248 (3) 1243-1247;

J

  1. Jackson, A

    1. Effects of phencyclidine and other N-methyl-D-aspartate antagonists on the schedule-controlled behavior of rats.
      D J Sanger and A Jackson
      Journal of Pharmacology and Experimental Therapeutics March 1989, 248 (3) 1215-1221;

  2. Jackson, E K

    1. Inhibition of renal vasoconstriction induced by intrarenal hypertonic saline by the nonxanthine adenosine antagonist CGS 15943A.
      J T Callis, C J Kuan, K R Branch, B C Abels, R Sabra, E K Jackson and R A Branch
      Journal of Pharmacology and Experimental Therapeutics March 1989, 248 (3) 1123-1129;

  3. Jakubow, J

    1. Effects of phenytoin and phenobarbital on schedule-controlled responding and seizure activity in the amygdala-kindled rat.
      G Renfrey, H Schlinger, J Jakubow and A Poling
      Journal of Pharmacology and Experimental Therapeutics March 1989, 248 (3) 967-973;

  4. Jones, S Y

    1. Role of renal nerves in excretory responses to exogenous and endogenous opioid peptides.
      D R Kapusta, S Y Jones, U C Kopp and G F Dibona
      Journal of Pharmacology and Experimental Therapeutics March 1989, 248 (3) 1039-1047;

  5. Juvent, M

    1. Interaction between nonsteroidal anti-inflammatory drugs and loop diuretics: modulation by sodium balance.
      A Herchuelz, F Derenne, F Deger, M Juvent, E Van Ganse, M Staroukine, A Verniory, J M Boeynaems and J Douchamps
      Journal of Pharmacology and Experimental Therapeutics March 1989, 248 (3) 1175-1181;

K

  1. Kamien, J B

    1. A pharmacological analysis of the discriminative stimulus properties of d-amphetamine in rhesus monkeys.
      J B Kamien and W L Woolverton
      Journal of Pharmacology and Experimental Therapeutics March 1989, 248 (3) 938-946;

  2. Kaplan, G B

    1. Relationship of plasma and brain concentrations of caffeine and metabolites to benzodiazepine receptor binding and locomotor activity.
      G B Kaplan, D J Greenblatt, B W Leduc, M L Thompson and R I Shader
      Journal of Pharmacology and Experimental Therapeutics March 1989, 248 (3) 1078-1083;

  3. Kapusta, D R

    1. Role of renal nerves in excretory responses to exogenous and endogenous opioid peptides.
      D R Kapusta, S Y Jones, U C Kopp and G F Dibona
      Journal of Pharmacology and Experimental Therapeutics March 1989, 248 (3) 1039-1047;

  4. Kates, R E

    1. In vivo evaluation of the effects of altered cyclosporine metabolism on its immunosuppressive potency.
      G Babany, R E Morris, I Babany, S Shepherd and R E Kates
      Journal of Pharmacology and Experimental Therapeutics March 1989, 248 (3) 893-899;

  5. Kauffman, F C

    1. Hepatotoxicity of menadione predominates in oxygen-rich zones of the liver lobule.
      M Z Badr, P E Ganey, H Yoshihara, F C Kauffman and R G Thurman
      Journal of Pharmacology and Experimental Therapeutics March 1989, 248 (3) 1317-1322;

  6. Kauppinen, R A

    1. Cellular mechanisms underlying the increase in cytosolic free calcium concentration induced by methylmercury in cerebrocortical synaptosomes from guinea pig.
      R A Kauppinen, H Komulainen and H Taipale
      Journal of Pharmacology and Experimental Therapeutics March 1989, 248 (3) 1248-1254;

  7. Kirk, W T

    1. Evaluation of the abuse potential of methocarbamol.
      K L Preston, J J Guarino, W T Kirk and R R Griffiths
      Journal of Pharmacology and Experimental Therapeutics March 1989, 248 (3) 1146-1157;

  8. Kishimoto, I

    1. Blood oxygen tension-related change of theophylline clearance in experimental hypoxemia.
      I Kishimoto, Y Tanigawara, K Okumura and R Hori
      Journal of Pharmacology and Experimental Therapeutics March 1989, 248 (3) 1237-1242;

  9. Klaassen, C D

    1. Biliary excretion of acetaminophen-glutathione as an index of toxic activation of acetaminophen: effect of chemicals that alter acetaminophen hepatotoxicity.
      C Madhu, Z Gregus and C D Klaassen
      Journal of Pharmacology and Experimental Therapeutics March 1989, 248 (3) 1069-1077;

  10. Komulainen, H

    1. Cellular mechanisms underlying the increase in cytosolic free calcium concentration induced by methylmercury in cerebrocortical synaptosomes from guinea pig.
      R A Kauppinen, H Komulainen and H Taipale
      Journal of Pharmacology and Experimental Therapeutics March 1989, 248 (3) 1248-1254;

  11. Konishi, M

    1. In vitro effect of naftidrofuryl oxalate on cerebral mitochondria impaired by microsphere-induced embolism in rats.
      S Takeo, K Miyake, R Minematsu, K Tanonaka and M Konishi
      Journal of Pharmacology and Experimental Therapeutics March 1989, 248 (3) 1207-1214;

  12. Kopp, U C

    1. Role of renal nerves in excretory responses to exogenous and endogenous opioid peptides.
      D R Kapusta, S Y Jones, U C Kopp and G F Dibona
      Journal of Pharmacology and Experimental Therapeutics March 1989, 248 (3) 1039-1047;

  13. Kosoglou, T

    1. Ranitidine-induced changes in the renal and hepatic clearances of procainamide are correlated.
      M L Rocci, T Kosoglou, R K Ferguson and P H Vlasses
      Journal of Pharmacology and Experimental Therapeutics March 1989, 248 (3) 923-928;

  14. Krause, J E

    1. Lithium increases rat striatal beta- and gamma-preprotachykinin messenger RNAs.
      S P Sivam, J E Krause, K Takeuchi, S Li, J F McGinty and J S Hong
      Journal of Pharmacology and Experimental Therapeutics March 1989, 248 (3) 1297-1301;

  15. Kuan, C J

    1. Inhibition of renal vasoconstriction induced by intrarenal hypertonic saline by the nonxanthine adenosine antagonist CGS 15943A.
      J T Callis, C J Kuan, K R Branch, B C Abels, R Sabra, E K Jackson and R A Branch
      Journal of Pharmacology and Experimental Therapeutics March 1989, 248 (3) 1123-1129;

  16. Kuhar, M J

    1. Relationship between self-administration of amphetamine and monoamine receptors in brain: comparison with cocaine.
      M C Ritz and M J Kuhar
      Journal of Pharmacology and Experimental Therapeutics March 1989, 248 (3) 1010-1017;

L

  1. Lanfumey, L

    1. Biochemical and electrophysiological evidence for an agonist action of CM 57493 at pre- and postsynaptic 5-hydroxytryptamine1A receptors in brain.
      J Adrien, L Lanfumey, H Gozlan, C M Fattaccini and M Hamon
      Journal of Pharmacology and Experimental Therapeutics March 1989, 248 (3) 1222-1230;

  2. Lauridsen, I N

    1. Dose dependency of furosemide-induced sodium excretion.
      F Andreasen, I N Lauridsen, F A Hansen, S Christensen and E Steiness
      Journal of Pharmacology and Experimental Therapeutics March 1989, 248 (3) 1182-1188;

  3. Lazarus, S C

    1. Mast cell tryptase and chymase reverse airway smooth muscle relaxation induced by vasoactive intestinal peptide in the ferret.
      G M Franconi, P D Graf, S C Lazarus, J A Nadel and G H Caughey
      Journal of Pharmacology and Experimental Therapeutics March 1989, 248 (3) 947-951;

  4. Leduc, B W

    1. Relationship of plasma and brain concentrations of caffeine and metabolites to benzodiazepine receptor binding and locomotor activity.
      G B Kaplan, D J Greenblatt, B W Leduc, M L Thompson and R I Shader
      Journal of Pharmacology and Experimental Therapeutics March 1989, 248 (3) 1078-1083;

  5. Levi, R

    1. C3a-induced contraction of guinea pig ileum consists of two components: fast histamine-mediated and slow prostanoid-mediated.
      U del Balzo, M J Polley and R Levi
      Journal of Pharmacology and Experimental Therapeutics March 1989, 248 (3) 1003-1009;

  6. Li, S

    1. Lithium increases rat striatal beta- and gamma-preprotachykinin messenger RNAs.
      S P Sivam, J E Krause, K Takeuchi, S Li, J F McGinty and J S Hong
      Journal of Pharmacology and Experimental Therapeutics March 1989, 248 (3) 1297-1301;

  7. Liebson, I A

    1. Antagonist effects of nalbuphine in opioid-dependent human volunteers.
      K L Preston, G E Bigelow and I A Liebson
      Journal of Pharmacology and Experimental Therapeutics March 1989, 248 (3) 929-937;

  8. Lopez, F

    1. Chronic benzodiazepine administration. III. Upregulation of gamma-aminobutyric acidA receptor binding and function associated with chronic benzodiazepine antagonist administration.
      L G Miller, D J Greenblatt, R B Roy, A Gaver, F Lopez and R I Shader
      Journal of Pharmacology and Experimental Therapeutics March 1989, 248 (3) 1096-1101;

M

  1. Madhu, C

    1. Biliary excretion of acetaminophen-glutathione as an index of toxic activation of acetaminophen: effect of chemicals that alter acetaminophen hepatotoxicity.
      C Madhu, Z Gregus and C D Klaassen
      Journal of Pharmacology and Experimental Therapeutics March 1989, 248 (3) 1069-1077;

  2. Makielski, J C

    1. Single channel sodium current in rat cardiomyocytes: use-dependent block by ethacizin.
      A I Undrovinas, N A Burnashev, V V Nesterenko, J C Makielski, I A Fleidervish, H A Fozzard and L V Rosenshtraukh
      Journal of Pharmacology and Experimental Therapeutics March 1989, 248 (3) 1138-1145;

  3. Marchi, M

    1. Interaction acetylcholine-glutamate in rat hippocampus: involvement of two subtypes of M-2 muscarinic receptors.
      M Marchi and M Raiteri
      Journal of Pharmacology and Experimental Therapeutics March 1989, 248 (3) 1255-1260;

  4. McCarthy, L A

    1. Terbinafine inhibits the mitogenic response to platelet-derived growth factor in vitro and neointimal proliferation in vivo.
      G M Nemecek, I H St Denny, R G Van Valen, L A McCarthy, D A Handley and A Stütz
      Journal of Pharmacology and Experimental Therapeutics March 1989, 248 (3) 1167-1174;

  5. McGinty, J F

    1. Lithium increases rat striatal beta- and gamma-preprotachykinin messenger RNAs.
      S P Sivam, J E Krause, K Takeuchi, S Li, J F McGinty and J S Hong
      Journal of Pharmacology and Experimental Therapeutics March 1989, 248 (3) 1297-1301;

  6. McKay, D B

    1. Structure-activity study on the actions of taxol and related taxanes on primary cultures of adrenal medullary cells.
      D B McKay
      Journal of Pharmacology and Experimental Therapeutics March 1989, 248 (3) 1302-1307;

  7. McMartin, K E

    1. Differential effects of acute ethanol on urinary excretion of folate derivatives in the rat.
      B H Eisenga, T D Collins and K E McMartin
      Journal of Pharmacology and Experimental Therapeutics March 1989, 248 (3) 916-922;

  8. McMurtry, I F

    1. Hypoxic contraction of isolated rat pulmonary artery.
      D M Rodman, T Yamaguchi, R F O'Brien and I F McMurtry
      Journal of Pharmacology and Experimental Therapeutics March 1989, 248 (3) 952-959;

  9. Mestre, M

    1. Vasorelaxant effects of cromakalim in rats are mediated by glibenclamide-sensitive potassium channels.
      I Cavero, S Mondot and M Mestre
      Journal of Pharmacology and Experimental Therapeutics March 1989, 248 (3) 1261-1268;

  10. Millan, M J

    1. Peripheral opioid receptors mediating antinociception in inflammation. Evidence for involvement of mu, delta and kappa receptors.
      C Stein, M J Millan, T S Shippenberg, K Peter and A Herz
      Journal of Pharmacology and Experimental Therapeutics March 1989, 248 (3) 1269-1275;

  11. Miller, L G

    1. Chronic benzodiazepine administration. III. Upregulation of gamma-aminobutyric acidA receptor binding and function associated with chronic benzodiazepine antagonist administration.
      L G Miller, D J Greenblatt, R B Roy, A Gaver, F Lopez and R I Shader
      Journal of Pharmacology and Experimental Therapeutics March 1989, 248 (3) 1096-1101;

  12. Minematsu, R

    1. In vitro effect of naftidrofuryl oxalate on cerebral mitochondria impaired by microsphere-induced embolism in rats.
      S Takeo, K Miyake, R Minematsu, K Tanonaka and M Konishi
      Journal of Pharmacology and Experimental Therapeutics March 1989, 248 (3) 1207-1214;

  13. Miyake, K

    1. In vitro effect of naftidrofuryl oxalate on cerebral mitochondria impaired by microsphere-induced embolism in rats.
      S Takeo, K Miyake, R Minematsu, K Tanonaka and M Konishi
      Journal of Pharmacology and Experimental Therapeutics March 1989, 248 (3) 1207-1214;

  14. Mohri, M

    1. Isosorbide dinitrate ameliorates myocardial ischemia after development of collateral function in a canine model.
      K Hisano, H Tomoike, T Inoue, M Mohri and M Nakamura
      Journal of Pharmacology and Experimental Therapeutics March 1989, 248 (3) 1289-1296;

  15. Mondot, S

    1. Vasorelaxant effects of cromakalim in rats are mediated by glibenclamide-sensitive potassium channels.
      I Cavero, S Mondot and M Mestre
      Journal of Pharmacology and Experimental Therapeutics March 1989, 248 (3) 1261-1268;

  16. Morris, R E

    1. In vivo evaluation of the effects of altered cyclosporine metabolism on its immunosuppressive potency.
      G Babany, R E Morris, I Babany, S Shepherd and R E Kates
      Journal of Pharmacology and Experimental Therapeutics March 1989, 248 (3) 893-899;

  17. Morselli, P L

    1. Pharmacokinetics, brain distribution and pharmaco-electrocorticographic profile of zolpidem, a new hypnotic, in the rat.
      D Garrigou-Gadenne, J T Burke, A Durand, H Depoortere, J P Thénot and P L Morselli
      Journal of Pharmacology and Experimental Therapeutics March 1989, 248 (3) 1283-1288;

N

  1. Nadel, J A

    1. Mast cell tryptase and chymase reverse airway smooth muscle relaxation induced by vasoactive intestinal peptide in the ferret.
      G M Franconi, P D Graf, S C Lazarus, J A Nadel and G H Caughey
      Journal of Pharmacology and Experimental Therapeutics March 1989, 248 (3) 947-951;

  2. Nagel, J

    1. Selective inhibitory effects of ethylketocyclazocine on reflex pathways to the external urethral sphincter of the cat.
      K B Thor, T Hisamitsu, J R Roppolo, P Tuttle, J Nagel and W C deGroat
      Journal of Pharmacology and Experimental Therapeutics March 1989, 248 (3) 1018-1025;

  3. Nakamura, M

    1. Isosorbide dinitrate ameliorates myocardial ischemia after development of collateral function in a canine model.
      K Hisano, H Tomoike, T Inoue, M Mohri and M Nakamura
      Journal of Pharmacology and Experimental Therapeutics March 1989, 248 (3) 1289-1296;

  4. Needleman, P

    1. Pharmacological manipulation of inflammation in rabbit hydronephrosis: effects of a combined cyclooxygenase/lipoxygenase inhibitor ethoxyquin, a thromboxane synthase inhibitor RS-5186 and a PAF antagonist L-659,989.
      S M Spaethe, W Hsueh and P Needleman
      Journal of Pharmacology and Experimental Therapeutics March 1989, 248 (3) 1308-1316;

  5. Nemecek, G M

    1. Terbinafine inhibits the mitogenic response to platelet-derived growth factor in vitro and neointimal proliferation in vivo.
      G M Nemecek, I H St Denny, R G Van Valen, L A McCarthy, D A Handley and A Stütz
      Journal of Pharmacology and Experimental Therapeutics March 1989, 248 (3) 1167-1174;

  6. Nesterenko, V V

    1. Single channel sodium current in rat cardiomyocytes: use-dependent block by ethacizin.
      A I Undrovinas, N A Burnashev, V V Nesterenko, J C Makielski, I A Fleidervish, H A Fozzard and L V Rosenshtraukh
      Journal of Pharmacology and Experimental Therapeutics March 1989, 248 (3) 1138-1145;

  7. Norman, A B

    1. Irreversible and quaternary muscarinic antagonists discriminate multiple muscarinic receptor binding sites in rat brain.
      A B Norman, J H Eubanks and I Creese
      Journal of Pharmacology and Experimental Therapeutics March 1989, 248 (3) 1116-1122;

O

  1. O'Brien, R F

    1. Hypoxic contraction of isolated rat pulmonary artery.
      D M Rodman, T Yamaguchi, R F O'Brien and I F McMurtry
      Journal of Pharmacology and Experimental Therapeutics March 1989, 248 (3) 952-959;

  2. Ogiwara, Y

    1. Beta-2 adrenoceptor-mediated effects on sinus rate and atrial and ventricular contractility on isolated, blood-perfused dog heart preparations.
      K Akahane, Y Furukawa, Y Ogiwara, M Haniuda and S Chiba
      Journal of Pharmacology and Experimental Therapeutics March 1989, 248 (3) 1276-1282;

  3. Ohno, Y

    1. Prevention of phencyclidine-induced depression of the segmental reflex by L-3,4-dihydroxyphenylalanine in the rat spinal cord in vitro.
      J S Carp, Y Ohno and J E Warnick
      Journal of Pharmacology and Experimental Therapeutics March 1989, 248 (3) 1048-1053;

  4. Okumura, K

    1. Blood oxygen tension-related change of theophylline clearance in experimental hypoxemia.
      I Kishimoto, Y Tanigawara, K Okumura and R Hori
      Journal of Pharmacology and Experimental Therapeutics March 1989, 248 (3) 1237-1242;

  5. Olsen, R W

    1. Steroid anesthetics and naturally occurring analogs modulate the gamma-aminobutyric acid receptor complex at a site distinct from barbiturates.
      D M Turner, R W Ransom, J S Yang and R W Olsen
      Journal of Pharmacology and Experimental Therapeutics March 1989, 248 (3) 960-966;

  6. Olsnes, S

    1. Effect of anti-inflammatory analgesic drugs on the regulation of cytosolic pH by anion antiport.
      T I Tønnessen, A T Aas, K Sandvig and S Olsnes
      Journal of Pharmacology and Experimental Therapeutics March 1989, 248 (3) 1197-1206;

  7. Owen, P J

    1. Characterization of bradykinin-stimulated release of noradrenaline from cultured bovine adrenal chromaffin cells.
      P J Owen, R Plevin and M R Boarder
      Journal of Pharmacology and Experimental Therapeutics March 1989, 248 (3) 1231-1236;

P

  1. Pechnick, R N

    1. Characterization of the effects of the acute and chronic administration of phencyclidine on body temperature in the rat: lack of evidence for the involvement of opiate receptors.
      R N Pechnick and R George
      Journal of Pharmacology and Experimental Therapeutics March 1989, 248 (3) 900-906;

  2. Peter, K

    1. Peripheral opioid receptors mediating antinociception in inflammation. Evidence for involvement of mu, delta and kappa receptors.
      C Stein, M J Millan, T S Shippenberg, K Peter and A Herz
      Journal of Pharmacology and Experimental Therapeutics March 1989, 248 (3) 1269-1275;

  3. Plevin, R

    1. Characterization of bradykinin-stimulated release of noradrenaline from cultured bovine adrenal chromaffin cells.
      P J Owen, R Plevin and M R Boarder
      Journal of Pharmacology and Experimental Therapeutics March 1989, 248 (3) 1231-1236;

  4. Poling, A

    1. Effects of phenytoin and phenobarbital on schedule-controlled responding and seizure activity in the amygdala-kindled rat.
      G Renfrey, H Schlinger, J Jakubow and A Poling
      Journal of Pharmacology and Experimental Therapeutics March 1989, 248 (3) 967-973;

  5. Polley, M J

    1. C3a-induced contraction of guinea pig ileum consists of two components: fast histamine-mediated and slow prostanoid-mediated.
      U del Balzo, M J Polley and R Levi
      Journal of Pharmacology and Experimental Therapeutics March 1989, 248 (3) 1003-1009;

  6. Porter, J H

    1. Effects of phencyclidine-like drugs on punished behavior in rats.
      J H Porter, J L Wiley and R L Balster
      Journal of Pharmacology and Experimental Therapeutics March 1989, 248 (3) 997-1002;

  7. Potter, L T

    1. Affinities of different cholinergic agonists for the high and low affinity states of hippocampal M1 muscarine receptors.
      L T Potter and C A Ferrendelli
      Journal of Pharmacology and Experimental Therapeutics March 1989, 248 (3) 974-978;

  8. Preston, K L

    1. Evaluation of the abuse potential of methocarbamol.
      K L Preston, J J Guarino, W T Kirk and R R Griffiths
      Journal of Pharmacology and Experimental Therapeutics March 1989, 248 (3) 1146-1157;
    2. Antagonist effects of nalbuphine in opioid-dependent human volunteers.
      K L Preston, G E Bigelow and I A Liebson
      Journal of Pharmacology and Experimental Therapeutics March 1989, 248 (3) 929-937;

  9. Purdy, R E

    1. Evidence for allosteric blockade of serotonergic receptors in rabbit thoracic aorta.
      Z Xu and R E Purdy
      Journal of Pharmacology and Experimental Therapeutics March 1989, 248 (3) 1091-1095;

R

  1. Raiteri, M

    1. Interaction acetylcholine-glutamate in rat hippocampus: involvement of two subtypes of M-2 muscarinic receptors.
      M Marchi and M Raiteri
      Journal of Pharmacology and Experimental Therapeutics March 1989, 248 (3) 1255-1260;

  2. Ransom, R W

    1. Steroid anesthetics and naturally occurring analogs modulate the gamma-aminobutyric acid receptor complex at a site distinct from barbiturates.
      D M Turner, R W Ransom, J S Yang and R W Olsen
      Journal of Pharmacology and Experimental Therapeutics March 1989, 248 (3) 960-966;

  3. Reed, M M

    1. Coupling of hepatic prostaglandin receptors to adenylate cyclase through a pertussis toxin sensitive guanine nucleotide regulatory protein.
      M J Garrity, M M Reed and E P Brass
      Journal of Pharmacology and Experimental Therapeutics March 1989, 248 (3) 979-983;

  4. Reisine, T

    1. Phorbol esters and corticotropin releasing factor stimulate calcium influx in the anterior pituitary tumor cell line, AtT-20, through different intracellular sites of action.
      T Reisine
      Journal of Pharmacology and Experimental Therapeutics March 1989, 248 (3) 984-990;

  5. Renfrey, G

    1. Effects of phenytoin and phenobarbital on schedule-controlled responding and seizure activity in the amygdala-kindled rat.
      G Renfrey, H Schlinger, J Jakubow and A Poling
      Journal of Pharmacology and Experimental Therapeutics March 1989, 248 (3) 967-973;

  6. Ritz, M C

    1. Relationship between self-administration of amphetamine and monoamine receptors in brain: comparison with cocaine.
      M C Ritz and M J Kuhar
      Journal of Pharmacology and Experimental Therapeutics March 1989, 248 (3) 1010-1017;

  7. Rocci, M L

    1. Ranitidine-induced changes in the renal and hepatic clearances of procainamide are correlated.
      M L Rocci, T Kosoglou, R K Ferguson and P H Vlasses
      Journal of Pharmacology and Experimental Therapeutics March 1989, 248 (3) 923-928;

  8. Rodman, D M

    1. Hypoxic contraction of isolated rat pulmonary artery.
      D M Rodman, T Yamaguchi, R F O'Brien and I F McMurtry
      Journal of Pharmacology and Experimental Therapeutics March 1989, 248 (3) 952-959;

  9. Roppolo, J R

    1. Selective inhibitory effects of ethylketocyclazocine on reflex pathways to the external urethral sphincter of the cat.
      K B Thor, T Hisamitsu, J R Roppolo, P Tuttle, J Nagel and W C deGroat
      Journal of Pharmacology and Experimental Therapeutics March 1989, 248 (3) 1018-1025;

  10. Rosenshtraukh, L V

    1. Single channel sodium current in rat cardiomyocytes: use-dependent block by ethacizin.
      A I Undrovinas, N A Burnashev, V V Nesterenko, J C Makielski, I A Fleidervish, H A Fozzard and L V Rosenshtraukh
      Journal of Pharmacology and Experimental Therapeutics March 1989, 248 (3) 1138-1145;

  11. Roy, R B

    1. Chronic benzodiazepine administration. III. Upregulation of gamma-aminobutyric acidA receptor binding and function associated with chronic benzodiazepine antagonist administration.
      L G Miller, D J Greenblatt, R B Roy, A Gaver, F Lopez and R I Shader
      Journal of Pharmacology and Experimental Therapeutics March 1989, 248 (3) 1096-1101;

S

  1. Sabra, R

    1. Inhibition of renal vasoconstriction induced by intrarenal hypertonic saline by the nonxanthine adenosine antagonist CGS 15943A.
      J T Callis, C J Kuan, K R Branch, B C Abels, R Sabra, E K Jackson and R A Branch
      Journal of Pharmacology and Experimental Therapeutics March 1989, 248 (3) 1123-1129;

  2. Sandvig, K

    1. Effect of anti-inflammatory analgesic drugs on the regulation of cytosolic pH by anion antiport.
      T I Tønnessen, A T Aas, K Sandvig and S Olsnes
      Journal of Pharmacology and Experimental Therapeutics March 1989, 248 (3) 1197-1206;

  3. Sanger, D J

    1. Effects of phencyclidine and other N-methyl-D-aspartate antagonists on the schedule-controlled behavior of rats.
      D J Sanger and A Jackson
      Journal of Pharmacology and Experimental Therapeutics March 1989, 248 (3) 1215-1221;

  4. Sato, C

    1. Mechanism of increased hepatotoxicity of acetaminophen by the simultaneous administration of caffeine in the rat.
      C Sato and N Izumi
      Journal of Pharmacology and Experimental Therapeutics March 1989, 248 (3) 1243-1247;

  5. Sawicki, G J

    1. Effects of ethmozin on excitability in sheep Purkinje fibers: the balance among active and passive cellular properties which comprise the electrophysiologic matrix.
      M F Arnsdorf and G J Sawicki
      Journal of Pharmacology and Experimental Therapeutics March 1989, 248 (3) 1158-1166;

  6. Schlinger, H

    1. Effects of phenytoin and phenobarbital on schedule-controlled responding and seizure activity in the amygdala-kindled rat.
      G Renfrey, H Schlinger, J Jakubow and A Poling
      Journal of Pharmacology and Experimental Therapeutics March 1989, 248 (3) 967-973;

  7. Schteingart, C D

    1. Role of bile acid conjugation in hepatic transport of dihydroxy bile acids.
      L M Clayton, D Gurantz, A F Hofmann, L R Hagey and C D Schteingart
      Journal of Pharmacology and Experimental Therapeutics March 1989, 248 (3) 1130-1137;

  8. Schumacher, W A

    1. Effect of thromboxane receptor antagonists on venous thrombosis in rats.
      W A Schumacher and C L Heran
      Journal of Pharmacology and Experimental Therapeutics March 1989, 248 (3) 1109-1115;

  9. Sesack, S R

    1. Pharmacological characterization of the receptor mediating electrophysiological responses to dopamine in the rat medial prefrontal cortex: a microiontophoretic study.
      S R Sesack and B S Bunney
      Journal of Pharmacology and Experimental Therapeutics March 1989, 248 (3) 1323-1333;

  10. Shader, R I

    1. Relationship of plasma and brain concentrations of caffeine and metabolites to benzodiazepine receptor binding and locomotor activity.
      G B Kaplan, D J Greenblatt, B W Leduc, M L Thompson and R I Shader
      Journal of Pharmacology and Experimental Therapeutics March 1989, 248 (3) 1078-1083;
    2. Chronic benzodiazepine administration. III. Upregulation of gamma-aminobutyric acidA receptor binding and function associated with chronic benzodiazepine antagonist administration.
      L G Miller, D J Greenblatt, R B Roy, A Gaver, F Lopez and R I Shader
      Journal of Pharmacology and Experimental Therapeutics March 1989, 248 (3) 1096-1101;

  11. Shepherd, S

    1. In vivo evaluation of the effects of altered cyclosporine metabolism on its immunosuppressive potency.
      G Babany, R E Morris, I Babany, S Shepherd and R E Kates
      Journal of Pharmacology and Experimental Therapeutics March 1989, 248 (3) 893-899;

  12. Shippenberg, T S

    1. Peripheral opioid receptors mediating antinociception in inflammation. Evidence for involvement of mu, delta and kappa receptors.
      C Stein, M J Millan, T S Shippenberg, K Peter and A Herz
      Journal of Pharmacology and Experimental Therapeutics March 1989, 248 (3) 1269-1275;

  13. Silbaugh, S A

    1. Reversal of A23187-induced airway constriction in the guinea pig.
      P W Stengel and S A Silbaugh
      Journal of Pharmacology and Experimental Therapeutics March 1989, 248 (3) 1084-1090;

  14. Sivam, S P

    1. Lithium increases rat striatal beta- and gamma-preprotachykinin messenger RNAs.
      S P Sivam, J E Krause, K Takeuchi, S Li, J F McGinty and J S Hong
      Journal of Pharmacology and Experimental Therapeutics March 1989, 248 (3) 1297-1301;

  15. Spaethe, S M

    1. Pharmacological manipulation of inflammation in rabbit hydronephrosis: effects of a combined cyclooxygenase/lipoxygenase inhibitor ethoxyquin, a thromboxane synthase inhibitor RS-5186 and a PAF antagonist L-659,989.
      S M Spaethe, W Hsueh and P Needleman
      Journal of Pharmacology and Experimental Therapeutics March 1989, 248 (3) 1308-1316;

  16. Staroukine, M

    1. Interaction between nonsteroidal anti-inflammatory drugs and loop diuretics: modulation by sodium balance.
      A Herchuelz, F Derenne, F Deger, M Juvent, E Van Ganse, M Staroukine, A Verniory, J M Boeynaems and J Douchamps
      Journal of Pharmacology and Experimental Therapeutics March 1989, 248 (3) 1175-1181;

  17. St Denny, I H

    1. Terbinafine inhibits the mitogenic response to platelet-derived growth factor in vitro and neointimal proliferation in vivo.
      G M Nemecek, I H St Denny, R G Van Valen, L A McCarthy, D A Handley and A Stütz
      Journal of Pharmacology and Experimental Therapeutics March 1989, 248 (3) 1167-1174;

  18. Stein, C

    1. Peripheral opioid receptors mediating antinociception in inflammation. Evidence for involvement of mu, delta and kappa receptors.
      C Stein, M J Millan, T S Shippenberg, K Peter and A Herz
      Journal of Pharmacology and Experimental Therapeutics March 1989, 248 (3) 1269-1275;

  19. Steiness, E

    1. Dose dependency of furosemide-induced sodium excretion.
      F Andreasen, I N Lauridsen, F A Hansen, S Christensen and E Steiness
      Journal of Pharmacology and Experimental Therapeutics March 1989, 248 (3) 1182-1188;

  20. Stengel, P W

    1. Reversal of A23187-induced airway constriction in the guinea pig.
      P W Stengel and S A Silbaugh
      Journal of Pharmacology and Experimental Therapeutics March 1989, 248 (3) 1084-1090;

  21. Stütz, A

    1. Terbinafine inhibits the mitogenic response to platelet-derived growth factor in vitro and neointimal proliferation in vivo.
      G M Nemecek, I H St Denny, R G Van Valen, L A McCarthy, D A Handley and A Stütz
      Journal of Pharmacology and Experimental Therapeutics March 1989, 248 (3) 1167-1174;

T

  1. Taipale, H

    1. Cellular mechanisms underlying the increase in cytosolic free calcium concentration induced by methylmercury in cerebrocortical synaptosomes from guinea pig.
      R A Kauppinen, H Komulainen and H Taipale
      Journal of Pharmacology and Experimental Therapeutics March 1989, 248 (3) 1248-1254;

  2. Takeo, S

    1. In vitro effect of naftidrofuryl oxalate on cerebral mitochondria impaired by microsphere-induced embolism in rats.
      S Takeo, K Miyake, R Minematsu, K Tanonaka and M Konishi
      Journal of Pharmacology and Experimental Therapeutics March 1989, 248 (3) 1207-1214;

  3. Takeuchi, K

    1. Lithium increases rat striatal beta- and gamma-preprotachykinin messenger RNAs.
      S P Sivam, J E Krause, K Takeuchi, S Li, J F McGinty and J S Hong
      Journal of Pharmacology and Experimental Therapeutics March 1989, 248 (3) 1297-1301;

  4. Tanigawara, Y

    1. Blood oxygen tension-related change of theophylline clearance in experimental hypoxemia.
      I Kishimoto, Y Tanigawara, K Okumura and R Hori
      Journal of Pharmacology and Experimental Therapeutics March 1989, 248 (3) 1237-1242;

  5. Tanonaka, K

    1. In vitro effect of naftidrofuryl oxalate on cerebral mitochondria impaired by microsphere-induced embolism in rats.
      S Takeo, K Miyake, R Minematsu, K Tanonaka and M Konishi
      Journal of Pharmacology and Experimental Therapeutics March 1989, 248 (3) 1207-1214;

  6. Thénot, J P

    1. Pharmacokinetics, brain distribution and pharmaco-electrocorticographic profile of zolpidem, a new hypnotic, in the rat.
      D Garrigou-Gadenne, J T Burke, A Durand, H Depoortere, J P Thénot and P L Morselli
      Journal of Pharmacology and Experimental Therapeutics March 1989, 248 (3) 1283-1288;

  7. Thompson, M L

    1. Relationship of plasma and brain concentrations of caffeine and metabolites to benzodiazepine receptor binding and locomotor activity.
      G B Kaplan, D J Greenblatt, B W Leduc, M L Thompson and R I Shader
      Journal of Pharmacology and Experimental Therapeutics March 1989, 248 (3) 1078-1083;

  8. Thor, K B

    1. Selective inhibitory effects of ethylketocyclazocine on reflex pathways to the external urethral sphincter of the cat.
      K B Thor, T Hisamitsu, J R Roppolo, P Tuttle, J Nagel and W C deGroat
      Journal of Pharmacology and Experimental Therapeutics March 1989, 248 (3) 1018-1025;

  9. Thurman, R G

    1. Hepatotoxicity of menadione predominates in oxygen-rich zones of the liver lobule.
      M Z Badr, P E Ganey, H Yoshihara, F C Kauffman and R G Thurman
      Journal of Pharmacology and Experimental Therapeutics March 1989, 248 (3) 1317-1322;

  10. Tomoike, H

    1. Isosorbide dinitrate ameliorates myocardial ischemia after development of collateral function in a canine model.
      K Hisano, H Tomoike, T Inoue, M Mohri and M Nakamura
      Journal of Pharmacology and Experimental Therapeutics March 1989, 248 (3) 1289-1296;

  11. Tønnessen, T I

    1. Effect of anti-inflammatory analgesic drugs on the regulation of cytosolic pH by anion antiport.
      T I Tønnessen, A T Aas, K Sandvig and S Olsnes
      Journal of Pharmacology and Experimental Therapeutics March 1989, 248 (3) 1197-1206;

  12. Turner, D M

    1. Steroid anesthetics and naturally occurring analogs modulate the gamma-aminobutyric acid receptor complex at a site distinct from barbiturates.
      D M Turner, R W Ransom, J S Yang and R W Olsen
      Journal of Pharmacology and Experimental Therapeutics March 1989, 248 (3) 960-966;

  13. Tuttle, P

    1. Selective inhibitory effects of ethylketocyclazocine on reflex pathways to the external urethral sphincter of the cat.
      K B Thor, T Hisamitsu, J R Roppolo, P Tuttle, J Nagel and W C deGroat
      Journal of Pharmacology and Experimental Therapeutics March 1989, 248 (3) 1018-1025;

U

  1. Undrovinas, A I

    1. Single channel sodium current in rat cardiomyocytes: use-dependent block by ethacizin.
      A I Undrovinas, N A Burnashev, V V Nesterenko, J C Makielski, I A Fleidervish, H A Fozzard and L V Rosenshtraukh
      Journal of Pharmacology and Experimental Therapeutics March 1989, 248 (3) 1138-1145;

V

  1. van den Buuse, M

    1. Differential effects of dopaminergic drugs on open-field behavior of spontaneously hypertensive rats and normotensive Wistar-Kyoto rats.
      M van den Buuse and W de Jong
      Journal of Pharmacology and Experimental Therapeutics March 1989, 248 (3) 1189-1196;

  2. Van Ganse, E

    1. Interaction between nonsteroidal anti-inflammatory drugs and loop diuretics: modulation by sodium balance.
      A Herchuelz, F Derenne, F Deger, M Juvent, E Van Ganse, M Staroukine, A Verniory, J M Boeynaems and J Douchamps
      Journal of Pharmacology and Experimental Therapeutics March 1989, 248 (3) 1175-1181;

  3. Van Valen, R G

    1. Terbinafine inhibits the mitogenic response to platelet-derived growth factor in vitro and neointimal proliferation in vivo.
      G M Nemecek, I H St Denny, R G Van Valen, L A McCarthy, D A Handley and A Stütz
      Journal of Pharmacology and Experimental Therapeutics March 1989, 248 (3) 1167-1174;

  4. Verniory, A

    1. Interaction between nonsteroidal anti-inflammatory drugs and loop diuretics: modulation by sodium balance.
      A Herchuelz, F Derenne, F Deger, M Juvent, E Van Ganse, M Staroukine, A Verniory, J M Boeynaems and J Douchamps
      Journal of Pharmacology and Experimental Therapeutics March 1989, 248 (3) 1175-1181;

  5. Vlasses, P H

    1. Ranitidine-induced changes in the renal and hepatic clearances of procainamide are correlated.
      M L Rocci, T Kosoglou, R K Ferguson and P H Vlasses
      Journal of Pharmacology and Experimental Therapeutics March 1989, 248 (3) 923-928;

W

  1. Warnick, J E

    1. Prevention of phencyclidine-induced depression of the segmental reflex by L-3,4-dihydroxyphenylalanine in the rat spinal cord in vitro.
      J S Carp, Y Ohno and J E Warnick
      Journal of Pharmacology and Experimental Therapeutics March 1989, 248 (3) 1048-1053;

  2. Warren, P H

    1. Effects of kappa opioids on schedule-controlled behavior of squirrel monkeys.
      J Bergman and P H Warren
      Journal of Pharmacology and Experimental Therapeutics March 1989, 248 (3) 1102-1108;

  3. Weichman, B M

    1. Pemedolac: a novel and long-acting non-narcotic analgesic.
      T T Chau and B M Weichman
      Journal of Pharmacology and Experimental Therapeutics March 1989, 248 (3) 907-915;

  4. Wilcox, G L

    1. Baclofen, gamma-aminobutyric acidB receptors and substance P in the mouse spinal cord.
      A S Hwang and G L Wilcox
      Journal of Pharmacology and Experimental Therapeutics March 1989, 248 (3) 1026-1033;
    2. Muscimol, gamma-aminobutyric acidA receptors and excitatory amino acids in the mouse spinal cord.
      L M Aanonsen and G L Wilcox
      Journal of Pharmacology and Experimental Therapeutics March 1989, 248 (3) 1034-1038;

  5. Wiley, J L

    1. Effects of phencyclidine-like drugs on punished behavior in rats.
      J H Porter, J L Wiley and R L Balster
      Journal of Pharmacology and Experimental Therapeutics March 1989, 248 (3) 997-1002;

  6. Woolverton, W L

    1. A pharmacological analysis of the discriminative stimulus properties of d-amphetamine in rhesus monkeys.
      J B Kamien and W L Woolverton
      Journal of Pharmacology and Experimental Therapeutics March 1989, 248 (3) 938-946;

X

  1. Xu, Z

    1. Evidence for allosteric blockade of serotonergic receptors in rabbit thoracic aorta.
      Z Xu and R E Purdy
      Journal of Pharmacology and Experimental Therapeutics March 1989, 248 (3) 1091-1095;

Y

  1. Yamaguchi, T

    1. Hypoxic contraction of isolated rat pulmonary artery.
      D M Rodman, T Yamaguchi, R F O'Brien and I F McMurtry
      Journal of Pharmacology and Experimental Therapeutics March 1989, 248 (3) 952-959;

  2. Yang, J S

    1. Steroid anesthetics and naturally occurring analogs modulate the gamma-aminobutyric acid receptor complex at a site distinct from barbiturates.
      D M Turner, R W Ransom, J S Yang and R W Olsen
      Journal of Pharmacology and Experimental Therapeutics March 1989, 248 (3) 960-966;

  3. Yoshihara, H

    1. Hepatotoxicity of menadione predominates in oxygen-rich zones of the liver lobule.
      M Z Badr, P E Ganey, H Yoshihara, F C Kauffman and R G Thurman
      Journal of Pharmacology and Experimental Therapeutics March 1989, 248 (3) 1317-1322;
Back to top

In this issue

Advertisement